Advertisement

Topics

Postpartum depression: new drug will be monitored at approved sites

09:55 EDT 26 Mar 2019 | British Medical Journal

The first drug approved by the US Food and Drug Administration for the treatment for postpartum depression will be administered only to short term inpatients at specially approved sites, as the FDA...

Original Article: Postpartum depression: new drug will be monitored at approved sites

NEXT ARTICLE

More From BioPortfolio on "Postpartum depression: new drug will be monitored at approved sites"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...